Phytase formulation

US10518233B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10518233-B2
Application numberUS-201414770766-A
CountryUS
Kind codeB2
Filing dateMar 10, 2014
Priority dateMar 14, 2013
Publication dateDec 31, 2019
Grant dateDec 31, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A liquid enzyme formulation, an enzyme granule formulation, methods for manufacturing enzyme granules using a fluid bed dryer, wherein the enzyme granules are thermostable without the need for a thermostable coating is provided. The enzyme granules are phytase granules used in the manufacturing of an animal feed, wherein the phytase granule is thermostable without the need for a thermostable coating and the phytase retains about 63% to about 134% of its activity after pelleting at 80° C.

First claim

Opening claim text (preview).

What is claimed is: 1. A liquid enzyme formulation comprising: (a) a phytase at a concentration of 5,000 to 50,000 unit/ml of the liquid enzyme formulation; (b) a buffer, at a concentration of 0.5%-2.5% w/v, wherein the buffer is selected from the group consisting of: a sodium citrate, potassium citrate, citric acid, sodium acetate, acetic acid, sodium phosphate, potassium phosphate and any combination thereof; (c) a stabilizer, at a concentration of 1%-40% w/v, wherein the stabilizer is selected from the group consisting of: a sucrose, a sorbitol, a mannitol, a glycerol, a trehalose, a sodium chloride, a sodium sulphate, or any combination thereof; and, (d) an anti-microbial, at a concentration of 0.05%-0.40% w/v, wherein the anti-microbial is selected from the group consisting of: a potassium sorbate, sodium sorbate, a sorbic acid, a sodium benzoate, a benzoic acid, a methyl paraben, a calcium propionate, a sodium propionate, an ammonium propionate, a propionic acid, or any combination thereof, wherein the phytase retains at least 63% of its activity at a temperature of 80° C. 2. The liquid enzyme formulation of claim 1 , wherein (a) the buffer has a pH in a range from 4.5 to about 5.50, (b) the stabilizer is a combination of at least two stabilizers, (c) the stabilizer is at a concentration between 5% to 30%, or (d) the anti-microbial is a combination of at least two anti-microbials. 3. The liquid enzyme formulation of claim 1 , wherein: (a) the phytase has a concentration of 5,000 to 20,000 unit/ml, (b) sodium chloride at a concentration of 1% to 20% w/v, (c) sorbitol at a concentration of 2% to 20% w/v, (d) glycerol at a concentration of 2% to 40% w/v, (e) potassium sorbate at a concentration of 0.05% to 0.4% w/v, (f) sodium benzoate at a concentration of 0.05% to 0.4% w/v, (g) methyl paraben at a concentration of 0.05% to 0.4% w/v, or (g) a propionate salt at a concentration of 0.05% to 0.4% w/v, wherein the propionate salt is selected from the group consisting of calcium propionate, sodium propionate, ammonium propionate, and any combination thereof. 4. The liquid enzyme formulation of claim 3 , wherein: (a) the phytase has a concentration of 10,000 unit/ml, (b) sodium chloride at a concentration of 15% w/v, (c) sorbitol at a concentration of 20% w/v, (d) glycerol at a concentration of 20% w/v, (e) potassium sorbate at a concentration of 0.20% w/v, (f) sodium benzoate at a concentration of 0.20% w/v, (g) methyl paraben at a concentration of 0.20% w/v, or (g) a propionate salt at a concentration of 0.20%, wherein the propionate salt is selected from the group consisting of calcium propionate, sodium propionate, ammonium propionate, and any combination thereof. 5. The liquid enzyme formulation of claim 1 , wherein: (a) the phytase has a concentration of 11,000 to 12,000 unit/ml, (b) sodium chloride at a concentration of 15% w/v, (c) sorbitol at a concentration of 4% w/v, (d) sodium citrate at a concentration of 50 mM, (e) potassium sorbate at a concentration of 0.2% w/v, (f) sodium benzoate at a concentration of 0.1% w/v, or (g) sodium propionate at a concentration of 0.1%. 6. The liquid enzyme formulation of claim 5 , wherein the stabilizer further comprises sorbitol at a concentration of 4% w/v and/or sucrose at a concentration of 6% w/v. 7. The liquid enzyme formulation of claim 1 , wherein: (a) the phytase has a concentration of 44,000 to 48,000 unit/ml, (b) sucrose at a concentration of 20% w/v, (c) sodium chloride at a concentration of 1% w/v, (d) sodium citrate at a concentration of 50 mM, (e) sodium benzoate at a concentration of 0.1% w/v, (f) potassium sorbate at a concentration of 0.4% w/v, or (g) sodium propionate at a concentration of 0.4%. 8. The liquid enzyme formulation of claim 7 , wherein the stabilizer further comprises sorbitol at a concentration of 2% to 40% w/v and/or sucrose at a concentration of 20% w/v. 9. The liquid enzyme formulation of claim 1 , wherein said liquid enzyme formulation comprises at least two of said anti-microbials. 10. The liquid enzyme formulation of claim 1 , wherein the liquid enzyme formulation is combined with an animal feed. 11. The liquid enzyme formulation of claim 10 , wherein the animal feed is a dry animal feed.

Assignees

Inventors

Classifications

  • 4-Phytase (3.1.3.26), i.e. 6-phytase · CPC title

  • 5-Phytase (3.1.3.72) · CPC title

  • 3-Phytase (3.1.3.8) · CPC title

  • C12N9/16Primary

    acting on ester bonds (3.1) · CPC title

  • B01J2/16Primary

    by suspending the powder material in a gas, e.g. in fluidised beds or as a falling curtain · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10518233B2 cover?
A liquid enzyme formulation, an enzyme granule formulation, methods for manufacturing enzyme granules using a fluid bed dryer, wherein the enzyme granules are thermostable without the need for a thermostable coating is provided. The enzyme granules are phytase granules used in the manufacturing of an animal feed, wherein the phytase granule is thermostable without the need for a thermostable co…
Who is the assignee on this patent?
Basf Enzymes Llc
What technology area does this patent fall under?
Primary CPC classification C12N9/16. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).